Economic Evaluation of Romiplostim Vs Eltrombopag In The Treatment of Adult Patients With Chronic Immune Thrombocytopenia In Mexico
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2693
https://www.valueinhealthjournal.com/article/S1098-3015(17)33027-9/fulltext
Title :
Economic Evaluation of Romiplostim Vs Eltrombopag In The Treatment of Adult Patients With Chronic Immune Thrombocytopenia In Mexico
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33027-9&doi=10.1016/j.jval.2017.08.2693
First page :
A893
Section Title :
SELECTED HEALTH CARE TREATMENT STUDIES -MEDICAL DEVICE/DIAGNOSTICS
Open access? :
No
Section Order :
2476